AngioWave Imaging is a Massachusetts-based medical AI company building post-processing software that sharpens fluoroscopic angiograms in the cardiac catheterization lab. Its FDA 510(k)-cleared AngioWaveNet uses a spatiotemporal, convolutional deep neural network (branded STEP) to reveal blood-vessel detail that is hard to see on the raw angiogram, helping interventional cardiologists diagnose and treat coronary artery disease. The software runs on top of any existing fluoroscopy system, requiring no new hardware.
Aram Salzman is the CEO and co-founder of AngioWave Imaging, a Boston-area medtech company building AI that sharpens the blurry, fast-moving X-ray movies cardiologists rely on during heart catheterizations. He is a serial healthcare founder whose earlier company, NovoBiotic Pharmaceuticals, produced teixobactin, the first new class of antibiotic discovered in decades. He also co-founded and exited CRA Health and Boston Lighthouse Innovations.